Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
Journal of Proteome Research
|
September 1, 2010
Proteomic profile regulated by the anticancer peptide CIGB-300 in non-small cell lung cancer (NSCLC) cells
Arielis Rodríguez-Ulloa, Yassel Ramos, Jeovanis Gil, et al.
Cancer Biology & Therapy
|
December 14, 2007
1E10 anti-idiotype vaccine in non-small cell lung cancer: experience in stage IIIb/IV patients
Saily Alfonso, Rosa M Diaz, Ana de la Torre, et al.
Viruses
|
October 27, 2022
Pin-Pointing the Key Hubs in the IFN-γ Pathway Responding to SARS-CoV-2 Infection
Ayelen Toro, Sofia Lage-Vickers, Juan Bizzotto, et al.
Eclinicalmedicine
|
June 30, 2021
Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial
Alejandro Krolewiecki, Adrián Lifschitz, Matías Moragas, et al.
Eclinicalmedicine
|
August 31, 2021
Corrigendum to Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial [EClinicalMedicine 37 (2021) 100,959]"
Alejandro Krolewiecki, Adrián Lifschitz, Matías Moragas, et al.
Springerplus
|
August 26, 2015
A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients
Ruth S Weinberg, Marcelo O Grecco, Gimena S Ferro, et al.
Resuscitation
|
October 13, 2020
Influence of the Covid-19 pandemic on out-of-hospital cardiac arrest. A Spanish nationwide prospective cohort study
Fernando Rosell Ortiz, Patricia Fernández Del Valle, Emily C Knox, et al.
Pediatric Blood & Cancer
|
May 15, 2026
Immune Response and Safety of Anti-NeuGcGM3 Anti-Idiotype Vaccine Racotumomab in Patients With High-Risk Neuroblastoma: An Open-Label, Single-Arm, Multicenter Phase 2 Study in Argentina
Guido Felizzia, Valeria I Segatori, Laura Galluzzo, et al.
Cell Death & Disease
|
November 28, 2024
Blood matters: the hematological signatures of Coronavirus infection
Ayelen Toro, Ana P Arévalo, Marianoel Pereira-Gómez, et al.
Molecular and Cellular Biochemistry
|
July 8, 2011
CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research
Silvio E Perea, Idania Baladron, Yanelda Garcia, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
Journal of Proteome Research
|
September 1, 2010
Proteomic profile regulated by the anticancer peptide CIGB-300 in non-small cell lung cancer (NSCLC) cells
Arielis Rodríguez-Ulloa, Yassel Ramos, Jeovanis Gil, et al.
Cancer Biology & Therapy
|
December 14, 2007
1E10 anti-idiotype vaccine in non-small cell lung cancer: experience in stage IIIb/IV patients
Saily Alfonso, Rosa M Diaz, Ana de la Torre, et al.
Viruses
|
October 27, 2022
Pin-Pointing the Key Hubs in the IFN-γ Pathway Responding to SARS-CoV-2 Infection
Ayelen Toro, Sofia Lage-Vickers, Juan Bizzotto, et al.
Eclinicalmedicine
|
June 30, 2021
Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial
Alejandro Krolewiecki, Adrián Lifschitz, Matías Moragas, et al.
Eclinicalmedicine
|
August 31, 2021
Corrigendum to Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial [EClinicalMedicine 37 (2021) 100,959]"
Alejandro Krolewiecki, Adrián Lifschitz, Matías Moragas, et al.
Springerplus
|
August 26, 2015
A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients
Ruth S Weinberg, Marcelo O Grecco, Gimena S Ferro, et al.
Resuscitation
|
October 13, 2020
Influence of the Covid-19 pandemic on out-of-hospital cardiac arrest. A Spanish nationwide prospective cohort study
Fernando Rosell Ortiz, Patricia Fernández Del Valle, Emily C Knox, et al.
Pediatric Blood & Cancer
|
May 15, 2026
Immune Response and Safety of Anti-NeuGcGM3 Anti-Idiotype Vaccine Racotumomab in Patients With High-Risk Neuroblastoma: An Open-Label, Single-Arm, Multicenter Phase 2 Study in Argentina
Guido Felizzia, Valeria I Segatori, Laura Galluzzo, et al.
Cell Death & Disease
|
November 28, 2024
Blood matters: the hematological signatures of Coronavirus infection
Ayelen Toro, Ana P Arévalo, Marianoel Pereira-Gómez, et al.
Molecular and Cellular Biochemistry
|
July 8, 2011
CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research
Silvio E Perea, Idania Baladron, Yanelda Garcia, et al.
Page
of 10